BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 19372206)

  • 1. Guanylyl cyclase-A inhibits angiotensin II type 2 receptor-mediated pro-hypertrophic signaling in the heart.
    Li Y; Saito Y; Kuwahara K; Rong X; Kishimoto I; Harada M; Adachi Y; Nakanishi M; Kinoshita H; Horiuchi M; Murray M; Nakao K
    Endocrinology; 2009 Aug; 150(8):3759-65. PubMed ID: 19372206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of AT2 blockade on cardiac hypertrophy as induced by high dietary salt in the proatrial natriuretic peptide (ANP) gene-disrupted mouse.
    Angelis E; Tse MY; Adams MA; Pang SC
    Can J Physiol Pharmacol; 2006 Jun; 84(6):625-34. PubMed ID: 16900247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guanylyl cyclase-A inhibits angiotensin II type 1A receptor-mediated cardiac remodeling, an endogenous protective mechanism in the heart.
    Li Y; Kishimoto I; Saito Y; Harada M; Kuwahara K; Izumi T; Takahashi N; Kawakami R; Tanimoto K; Nakagawa Y; Nakanishi M; Adachi Y; Garbers DL; Fukamizu A; Nakao K
    Circulation; 2002 Sep; 106(13):1722-8. PubMed ID: 12270869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasodilator therapy with hydralazine induces angiotensin AT receptor-mediated cardiomyocyte growth in mice lacking guanylyl cyclase-A.
    Li Y; Saito Y; Kuwahara K; Rong X; Kishimoto I; Harada M; Horiuchi M; Murray M; Nakao K
    Br J Pharmacol; 2010 Mar; 159(5):1133-42. PubMed ID: 20136844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac-specific overexpression of angiotensin II AT2 receptor causes attenuated response to AT1 receptor-mediated pressor and chronotropic effects.
    Masaki H; Kurihara T; Yamaki A; Inomata N; Nozawa Y; Mori Y; Murasawa S; Kizima K; Maruyama K; Horiuchi M; Dzau VJ; Takahashi H; Iwasaka T; Inada M; Matsubara H
    J Clin Invest; 1998 Feb; 101(3):527-35. PubMed ID: 9449684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The angiotensin II type 2 receptor causes constitutive growth of cardiomyocytes and does not antagonize angiotensin II type 1 receptor-mediated hypertrophy.
    D'Amore A; Black MJ; Thomas WG
    Hypertension; 2005 Dec; 46(6):1347-54. PubMed ID: 16286564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II type 2 receptor vasoactivity in internal mammary arteries of patients with coronary artery disease.
    van de Wal RM; van der Harst P; Wagenaar LJ; Wassmann S; Morshuis WJ; Nickenig G; Buikema H; Plokker HW; van Veldhuisen DJ; van Gilst WH; Voors AA
    J Cardiovasc Pharmacol; 2007 Oct; 50(4):372-9. PubMed ID: 18049304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcineurin-nuclear factor of activated T cells pathway-dependent cardiac remodeling in mice deficient in guanylyl cyclase A, a receptor for atrial and brain natriuretic peptides.
    Tokudome T; Horio T; Kishimoto I; Soeki T; Mori K; Kawano Y; Kohno M; Garbers DL; Nakao K; Kangawa K
    Circulation; 2005 Jun; 111(23):3095-104. PubMed ID: 15939815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flow-dependent dilation mediated by endogenous kinins requires angiotensin AT2 receptors.
    Bergaya S; Hilgers RH; Meneton P; Dong Y; Bloch-Faure M; Inagami T; Alhenc-Gelas F; Lévy BI; Boulanger CM
    Circ Res; 2004 Jun; 94(12):1623-9. PubMed ID: 15131008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for a functional role of angiotensin II type 2 receptor in the cardiac hypertrophic process in vivo in the rat heart.
    Lakó-Futó Z; Szokodi I; Sármán B; Földes G; Tokola H; Ilves M; Leskinen H; Vuolteenaho O; Skoumal R; deChâtel R; Ruskoaho H; Tóth M
    Circulation; 2003 Nov; 108(19):2414-22. PubMed ID: 14568903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aliskiren reduces myocardial ischemia-reperfusion injury by a bradykinin B2 receptor- and angiotensin AT2 receptor-mediated mechanism.
    Koid SS; Ziogas J; Campbell DJ
    Hypertension; 2014 Apr; 63(4):768-73. PubMed ID: 24420538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors.
    Liu YH; Yang XP; Sharov VG; Nass O; Sabbah HN; Peterson E; Carretero OA
    J Clin Invest; 1997 Apr; 99(8):1926-35. PubMed ID: 9109437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin AT2 receptor contributes to cardiovascular remodelling of aged rats during chronic AT1 receptor blockade.
    Jones ES; Black MJ; Widdop RE
    J Mol Cell Cardiol; 2004 Nov; 37(5):1023-30. PubMed ID: 15522279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of AT1 receptor in isoproterenol-induced cardiac hypertrophy and oxidative stress in mice.
    Zhang GX; Ohmori K; Nagai Y; Fujisawa Y; Nishiyama A; Abe Y; Kimura S
    J Mol Cell Cardiol; 2007 Apr; 42(4):804-11. PubMed ID: 17350036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of an AT1 receptor antagonist (CV-11974) on angiotensin II-induced cardiomyocyte hypertrophy in vitro.
    Hirata Y; Kanno K; Eguchi S; Kano H
    Blood Press Suppl; 1994; 5():84-8. PubMed ID: 7889209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of stunned myocardium in dogs with olmesartan, an angiotensin II type 1 receptor antagonist, is independent of type 2 receptors.
    Kano S; Satoh K; Kaneta S; Ichihara K
    Pharmacology; 2008; 82(1):22-9. PubMed ID: 18434761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway.
    Nagai N; Izumi-Nagai K; Oike Y; Koto T; Satofuka S; Ozawa Y; Yamashiro K; Inoue M; Tsubota K; Umezawa K; Ishida S
    Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4342-50. PubMed ID: 17724226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Alteration of signal transduction-associated gene expression in rat cardiac fibroblasts induced by blocking angiotensin II receptors].
    Jiang XY; Gao GD; Wang XF; Lin YX; Wang YW; Yang YB
    Sheng Li Xue Bao; 2006 Dec; 58(6):556-66. PubMed ID: 17173190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II type 2 receptor blockade partially negates antihypertrophic effects of type 1 receptor blockade on pressure-overload rat cardiac hypertrophy.
    Mukawa H; Toki Y; Miyazaki Y; Matsui H; Okumura K; Ito T
    Hypertens Res; 2003 Jan; 26(1):89-95. PubMed ID: 12661917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The renin-angiotensin system and experimental heart failure.
    Wollert KC; Drexler H
    Cardiovasc Res; 1999 Sep; 43(4):838-49. PubMed ID: 10615411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.